Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial assessing safety and efficacy of the 10 GE Xenokidney in adults with end-stage renal disease, including kidney transplantation contexts…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenokidney (10 GE)

Snippet

Sponsor: United Therapeutics | Conditions: ESRD (End-Stage Renal Disease), Kidney Transplantation | Phase 1, Phase 2 | Status: RECRUITING